Effect of a pulmonary embolism diagnostic strategy on clinical outcomes in patients hospitalized for COPD exacerbation: A randomized clinical trial
JAMA Oct 09, 2021
Jiménez D, Agustí A, Tabernero E, et al. - Among patients hospitalized for an exacerbation of COPD, no improvement in a composite set of health outcomes was observed in correlation with adding an active diagnostic strategy for pulmonary embolism (D-dimer testing and, if positive, computed tomography pulmonary angiogram) to usual care when compared with providing usual care alone.
A multicenter randomized clinical trial was performed including 746 patients who required hospitalization for exacerbation of COPD.
Participants received either usual care plus an active strategy for diagnosing pulmonary embolism or usual care alone.
29.7% of the patients in the intervention group and 29.2% of the patients in the control group had occurrence of the primary outcome (a composite of nonfatal symptomatic venous thromboembolism, readmission for COPD, or death within 90 days after randomization); the difference was not statistically significant.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries